Relibeta™ (recombinant interferon beta-1a)

Reliance Life Sciences Pvt. Ltd. provides biopharmaceuticals, pharmaceuticals, products and services which includes relibeta™ (recombinant interferon beta-1a). It belongs to biosimilars products category. It is a glycosylated protein with a single n-linked glycosylation site, similar to the natural interferon beta-1a. It is a 166 amino acid glycoprotein with a molecular weight of approximately 22 kd. It is produced by recombinant dna technology using genetically engineered chinese hamster ovary cells into which the human interferon beta gene has been introduced. The amino acid sequence of relibeta™ is identical to that of natural human interferon beta.